Please ensure Javascript is enabled for purposes of website accessibility

SEC Filing Details

Document Details

Form
Filing Date
Feb 12, 2025
Document Date
Feb 12, 2025
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Aardvark Therapeutics, Inc.
Issuer
Aardvark Therapeutics, Inc.
Filer
Cormorant Asset Management, LP